Utilizing Single-Cell Analysis of IBD Patient Samples to Identify Disease-Driving Targets in Patient Subsets – Anti-TREM1 as an Exciting New Approach for IBD Patients
Time: 4:30 pm
day: Day One
Details:
- Discussing matching novel therapeutic interventions to patient subsets to improve individual patient outcomes
- Identifying targetable disease-driving mechanisms in defined patients subsets through single-cell characterization of IBD tissue samples combined with clinical metadata
- Exploring the potential of TREM1 inhibition to reset the pathological relationship between the immune system and intestinal bacteria in IBD
